Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist

Pharmacology Biochemistry and Behavior

Volumn 83, Issue 1, 2006, Pages 109-113

  McCurdy, Christopher R ^a,b,c   Sufka, Kenneth J ^b,c   Smith, Grant H ^a   Warnick, Jason E ^b   Nieto, Marcelo J ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Acetic acid writhing; Antinociception; Hotplate; Kappa opioid receptor agonist; Mouse; Salvinorin A; Tail flick

Indexed keywords

ACETIC ACID; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE; SALVINORIN A;

ABDOMINAL WALL MUSCULATURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG STRUCTURE; HOT PLATE TEST; MALE; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ACETIC ACID; ANALGESICS; ANIMALS; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAT; MALE; MICE; MUSCLE CONTRACTION; NALTREXONE; NOCICEPTORS; PAIN MEASUREMENT; PLANT LEAVES; PSYCHOTROPIC DRUGS; REACTION TIME; RECEPTORS, OPIOID, KAPPA;

ANIMALIA;

EID: 33644913931     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.12.011     Document Type: Article

References (27)

1. W. Binder, H. Machelska, S. Mousa, T. Schmitt, P.J. Riviere, and J.-L. Junien Analgesic and anti-inflammatory effects of two novel kappa-opioid peptides Anesthesiology 94 2001 1034 1044
2. R.J. Bodnar Recent advances in the understanding of the effects of opioid agents on feeding and appetite Exp Opin Investig Drugs 7 1998 485 497
3. E.R. Butelman, T.J. Harris, and M.J. Kreek The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys Psychopharmacology 172 2004 220 224
4. C. Chavkin, S. Sud, W. Jin, J. Stewart, J.K. Zjawiony, and D.J. Siebert Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum is a highly efficacious kappa opioid receptor agonist: structural and functional considerations J Pharmacol Exp Ther 308 2004 1197 1203
5. M. Delvaux Pharmacology and clinical experience with fedotozine Exp Opin Investig Drugs 10 2001 97 110
6. T. Endoh, H. Matsuura, C. Tanaka, and H. Nagase Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo Arch Int Pharmacodyn Ther 316 1992 30 42
7. W.E. Fantegrossi, K.M. Kugle, L.J. Valdes III, M. Koreeda, and J.H. Woods Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse Behav Pharmacol 16 2005 627 633
8. K. Gulati, A. Ray, and K.K. Sharma Role of diurnal variation and receptor specificity in the opioidergic regulation of food intake in free-fed and food-deprived rats Physiol Behav 49 1991 1065 1071
9. K.R. Hanes Antidepressant effects of the herb Salvia divinorum: a case report J Clin Psychopharmacol 21 2001 634 635
10. W.W. Harding, K. Tidgewell, N. Byrd, H. Cobb, C.M. Dersch, and E.R. Butelman Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands J Med Chem 48 2005 4765 4771
11. G.E. Leighton, R.G. Hill, and J. Hughes The effects of kappa agonist PD-117302 on feeding behavior in obese and lean Zucker rats Pharmacol Biochem Behav 31 1988 425 429
12. J.R. Lokensgard, G. Gekker, and P.K. Peterson Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes Biochem Pharmacol 63 2002 1037 1041
13. M.A. Marrazzi, J. Lawhorn, V. Graham, D. L'Abbe, J. Mullings-Britton, and L. Stack Effects of U50,488, a selective kappa agonist, on atypical mouse opiate systems Brain Res Bull 25 1990 199 201
14. J.S. Mogil, S.G. Wilson, and Y. Wan Assessing nociception in murine subjects L. Kruger Methods in Pain Research 2001 CRC Press Boca Raton 11 39
15. T.A. Munro, and M.A. Rizzacasa Salvinorins D-F, new neclerodane diterpenoids from Salvia divinorum, and an improved method for isolation of salvinorin A J Nat Prod 66 2003 703 705
16. H. Nagase, T. Endoh, T. Suzuki, K. Kawamura, K. Oshima, and H. Inada Remedies for drug addiction WO 9911289 A1, PCT Int. Appl. 1999 Toray Industries, Inc. Japan 59 pp.
17. A. Ortega, J.F. Blount, and P.S. Manchand Salvinorin, a new trans-neoclerodane diterpene from Salvia divinorum (Labiatae) J Chem Soc, Perkin Trans 1 1982 2505 2508
18. G.W. Pasternak Pharmacological mechanisms of opioid analgesia Clin Neuropharmacol 16 1993 1 18
19. B.L. Roth, K. Baner, R. Westkaemper, D. Siebert, K.C. Rice, and S. Steinberg Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist Proc Natl Acad Sci U S A 99 2002 11934 11939
20. G. Schlechtingen, and M. Goodman New dynorphin analogs: highly selective ligands for the kappa-opioid receptor MEDI-220. Book of Abstracts, 217th American Chemical Society national Meeting, Anaheim, CA 1999
21. M.D. Schmidt, M.S. Schmidt, E.R. Butelman, W.W. Harding, K. Tidgewell, and D.J. Murry Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates Synapse 58 2005 208 210
22. D.J. Siebert Salvia divinorum and salvinorin A: new pharmacologic findings J Ethnopharmacol 43 1994 53 56
23. P.F. Smith, and C.L. Darlington The development of drugs targeting the HIV cognitive-motor complex Int J Immunother 15 2000 31 34
24. M. Ukai, M. Suzuki, and T. Mamiya Effects of U-50,488 H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice J Neural Transm 109 2002 1221 1225
25. L.J. Valdes III, J.L. Diaz, and A.G. Paul Ethnopharmacology of Ska Maria Pastora (Salvia divinorum, Epling and Jativa-M.) J Ethnopharmacol 7 1983 287 312
26. Y. Wang, K. Tang, S. Inan, D. Siebert, U. Holzgrabe, and D.Y.W. Lee Comparison of pharmacological activities of three distinct kappa ligands (salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo J Pharmacol Exp Ther 312 2005 220 230
27. Y. Zhang, E.R. Butleman, S.D. Schulussman, A. Ho, and M.J. Kreek Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors Psychopharmacology 179 2005 551 558